Article Information
vol. 12 no. 560
- Received for publication April 24, 2019
- Resubmitted December 31, 2019
- Accepted for publication August 14, 2020
- .
Author Information
- Veli-Matti Leppänen1,2,*,
- Pascal Brouillard3,*,
- Emilia A. Korhonen1,
- Tuomas Sipilä1,
- Sawan Kumar Jha2,
- Nicole Revencu4,
- Veerle Labarque5,
- Elodie Fastré3,
- Matthieu Schlögel3,
- Marie Ravoet4,
- Amihood Singer6,
- Claudia Luzzatto7,
- Donatella Angelone8,
- Giovanni Crichiutti9,
- Angela D’Elia9,
- Jaakko Kuurne1,
- Harri Elamaa10,
- Gou Young Koh11,12,
- Pipsa Saharinen1,2,
- Miikka Vikkula3,13,†,‡ and
- Kari Alitalo1,2,†,‡
- 1Wihuri Research Institute, Biomedicum Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.
- 2Translational Cancer Medicine Program, Faculty of Medicine and Helsinki Institute of Life Science, 00014 University of Helsinki, Finland.
- 3Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium.
- 4Center for Human Genetics, Cliniques universitaires Saint-Luc, University of Louvain, 1200 Brussels, Belgium.
- 5Centre for Molecular and Vascular Biology, University of Leuven, 3000 Leuven, Belgium.
- 6Barzilai Medical Center, 78306 Ashekelon, Israel.
- 7Padova University Hospital, 35128 Padova, Italy.
- 8A. Gemelli Hospital, 00168 Roma, Italy.
- 9Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, 33100 Udine, Italy.
- 10Oulu Centre for Cell-Matrix Research, Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
- 11Center for Vascular Research, Institute of Basic Science (IBS), 34141 Daejeon, Republic of Korea.
- 12Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), 34141 Daejeon, Republic of Korea.
- 13Walloon Excellence in Lifesciences and Biotechnology (WELBIO), University of Louvain, 1200 Brussels, Belgium.
- ↵‡Corresponding author. Email: miikka.vikkula{at}uclouvain.be (M.V.); kari.alitalo{at}helsinki.fi (K.A.)